Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety, Tolerability and Efficacy of AntiBKV As Treatment of BKV Infection in Kidney Transplant Recipients, a Randomized Phase II/III Study, Double-blind and Placebo-controlled

Next Previous
Trial Profile

Safety, Tolerability and Efficacy of AntiBKV As Treatment of BKV Infection in Kidney Transplant Recipients, a Randomized Phase II/III Study, Double-blind and Placebo-controlled

Status: Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 24 Jun 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Potravitug (Primary)
  • Indications Polyomavirus infections
  • Focus Proof of concept; Registrational; Therapeutic Use
  • Acronyms SAFE KIDNEY II
  • Sponsors Memo Therapeutics

Most Recent Events

  • 19 Jun 2025 According to a Memo Therapeutics media release, data from this trial will be presented at the World Transplant Congress (WTC) in San Francisco taking place 2-6 August 2025.
  • 13 Mar 2025 Planned End Date changed from 1 Jul 2025 to 19 Mar 2025.
  • 13 Mar 2025 Planned primary completion date changed from 1 Jul 2025 to 19 Mar 2025.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top